Waverley Pharma (STU:5GZ) Net Income (Continuing Operations) : €-2.07 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Waverley Pharma Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Waverley Pharma's Net Income (Continuing Operations) for the three months ended in Sep. 2024 was €-0.59 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was €-2.07 Mil.

Waverley Pharma Net Income (Continuing Operations) Historical Data

The historical data trend for Waverley Pharma's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Net Income (Continuing Operations) Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-0.83

-0.45

-0.55

-0.46

-1.52

Waverley Pharma Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-0.17	-0.62	-1.31	-0.18	-0.59

Waverley Pharma Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.07 Mil.

Waverley Pharma (STU:5GZ) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Waverley Pharma Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (STU:5GZ) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

WAVE:Canada

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Bortezomib, Pemetrexed, Capecitabine, and Temozolomide, among others.

Waverley Pharma Headlines

No Headlines